SCM
PLSE icon

Sterling Capital Management’s Pulse Biosciences PLSE Stock Holding History

Sterling Capital Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.48K Hold
115
– – ﹤0.01% 2945
2025
Q4 		$1.58K Buy
115
+72
+167% +$1.12K ﹤0.01% 3094
2025
Q3 		$761 Hold
43
– – ﹤0.01% 3115
2025
Q2 		$649 Buy
43
+24
+126% +$398 ﹤0.01% 3122
2025
Q1 		$306 Hold
19
– – ﹤0.01% 3036
2024
Q4 		$331 Hold
19
– – ﹤0.01% 3075
2024
Q3 		$333 Buy
+19
New +$324 ﹤0.01% 3007

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Sterling Capital Management's PLSE Position: Q1 2026 in Review

Sterling Capital Management held its Pulse Biosciences (PLSE) position steady in Q1 2026 at 115 shares worth $2.48K. The position accounts for ﹤0.01% of the portfolio, ranked #2945.

Sterling Capital Management first reported a position in PLSE in Q3 2024 and has held it in 7 quarters since. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Sterling Capital Management held 115 shares of Pulse Biosciences worth $2.48K as of Q1 2026.
  • Sterling Capital Management left its Pulse Biosciences share count unchanged in Q1 2026.
  • Pulse Biosciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #2945 holding.
  • Sterling Capital Management first reported a position in Pulse Biosciences in Q3 2024 and has held it in 7 quarters since.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.